Find Reports
Select Report Type
Reimbursement Review
Displaying 1401 - 1425 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| trabectedin | N/A | trabectedin | Soft tissue and uterine leiomyosarcoma | Active | PX0377-000 | ||||
| tofersen | Qalsody | tofersen | Amyotrophic lateral sclerosis (ALS) | Active | SR0883-000 | ||||
| nemolizumab | TBC | nemolizumab | atopic dermatitis | Active | SR0869-000 | ||||
| Hodgkin lymphoma | Hodgkin lymphoma | Open for Input | PH0079-000 | ||||||
| Prostate cancer | Prostate cancer | Open for Input | PH0073-000 | ||||||
| Mesothelioma | Mesothelioma | Active | PH0077-000 | ||||||
| Multiple myeloma | Multiple myeloma | Open for Input | PH0074-000 | ||||||
| Endometrial cancer | Endometrial cancer | Active | PH0076-000 | ||||||
| Renal cell carcinoma | Renal cell carcinoma | Open for Input | PH0075-000 | ||||||
| mirikizumab | Omvoh | mirikizumab | Crohn’s disease | Active | SR0880-000 | ||||
| leniolisib | TBC | leniolisib | Activated phosphoinositide 3 kinase delta syndrome | Suspended | SR0792-000 | ||||
| rozanolixizumab | Rystiggo | rozanolixizumab | Generalized myasthenia gravis (gMG) | Active | SR0846-000 | ||||
| imiquimod | N/A | imiquimod | Gynecological cancers | Withdrawn | PX0364-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| ferric carboxymaltose | Ferinject | ferric carboxymaltose | Iron deficiency in adult patients with heart failure | Active | SR0852-000 | ||||
| Nab-paclitaxel | N/A | Nab-paclitaxel | Gastrointestinal cancer | Do not reimburse | Complete | PX0354-000 | |||
| elafibranor | Iqirvo | elafibranor | Primary biliary cholangitis (PBC) | Active | SR0865-000 | ||||
| bulevirtide | Hepcludex | bulevirtide | chronic hepatitis delta virus (HDV) infection | Active | SR0881-000 | ||||
| odevixibat | Bylvay | odevixibat | Alagille syndrome | Active | SR0884-000 | ||||
| mirvetuximab soravtansine | TBC | mirvetuximab soravtansine | Epithelial ovarian, fallopian tube, or primary peritoneal cancer | Active | PC0394-000 | ||||
| ribociclib | Kisqali | ribociclib | Adjuvant treatment of HR-positive, HER2-negative early breast cancer | Active | PC0395-000 | ||||
| darolutamide | Nubeqa | darolutamide | Metastatic castration-sensitive prostate cancer | Received | PC0404-000 | ||||
| Mantle cell lymphoma | Mantle cell lymphoma | Active | PH0087-000 | ||||||
| Gastric cancer | Gastric cancer | Merged | PH0080-000 | ||||||
| Diffuse large B cell lymphoma ... | Diffuse large B | Open for Input | PH0078-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1401 - 1425 of 2138
Please scroll or swipe to the right to view the full content.
Provisional Funding Algorithm
Displaying 76 - 81 of 81